CAS 106094-36-4

1,3,2-Benzodioxaborole, 2-(1-butenyl)-, (E)-

Description:

1,3,2-Benzodioxaborole, 2-(1-butenyl)-, (E)- is an organic compound characterized by its unique structure that includes a benzodioxaborole moiety and a butenyl substituent. This compound features a boron atom integrated into a dioxaborole ring, which contributes to its reactivity and potential applications in organic synthesis and materials science. The (E)- configuration indicates that the butenyl group is in the trans orientation relative to the dioxaborole ring, influencing its stereochemistry and potentially its biological activity. Typically, compounds of this nature exhibit properties such as solubility in organic solvents, and they may participate in various chemical reactions, including cross-coupling and polymerization processes. The presence of the boron atom can also impart unique electronic properties, making it valuable in the development of boron-containing materials and pharmaceuticals. Overall, 1,3,2-Benzodioxaborole, 2-(1-butenyl)-, (E)- is of interest in both academic research and industrial applications due to its distinctive structural features and reactivity.

Formula: C₁₀H₁₁BO₂

(E)-2-(1-Butenyl)-1,3,2-benzodioxaborole

CAS: 106094-36-4

Formula: C₁₀H₁₁BO₂

Color and Shape: Liquid

Molecular weight: 174.0041

Ref: IN-DA008WP3

(E)-2-(1-Butenyl)-1,3,2-benzodioxaborole

Controlled Product

CAS: 106094-36-4

Applications (E)-2-(1-Butenyl)-1,3,2-benzodioxaborole (cas# 106094-36-4) is a compound useful in organic synthesis.

Formula: C₁₀H₁₁BO₂

Color and Shape: Neat

Molecular weight: 174.0

Ref: TR-B689975

(E)-2-(1-Butenyl)-1,3,2-benzodioxaborole

CAS: 106094-36-4

(E)-2-(1-Butenyl)-1,3,2-benzodioxaborole is a novel glycogen synthase inhibitor that has been shown to be effective in diabetic animal models. It was found to inhibit the activity of glycogen phosphorylase and increase the level of glycogen in the liver. (E)-2-(1-Butenyl)-1,3,2-benzodioxaborole has been optimized by replacing one or more of its moieties with anthranilimide groups. This replacement increases potency by 2 orders of magnitude with nanomolar potency. (E)-2-(1-Butenyl)-1,3,2-benzodioxaborole inhibits xanthine oxidase and xanthine dehydrogenase enzymes and prevents the formation of uric acid from xanthine during purine metabolism. It also inhibits glycolysis and glucose production through inhibition of phosphofructokinase 1.

Formula: C₁₀H₁₁BO₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 174 g/mol

Ref: 3D-FB19381